Lenivia is the first long-acting canine…
Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.
Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains…
Zoetis has launched a 4ml vial of the antibiotic, Convenia.
Zoetis says Convenia gives veterinary surgeons control by providing an assured injectable treatment course, relieving clients of the burden of daily dosing. This avoids missed or mistimed…
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated…
Zoetis has launched PetDialog and HorseDialog, the only treatment reminder apps for pet and horse owners which veterinary practices can customise with their own branding.
The app is downloadable from the Apple and Android app stores, but is only accessible…
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein…
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than…
Zoetis has launched a new training programme for veterinary practices which explores every aspect of the 'client journey' - from 'pre-owner' to 'Lost' - and explains how to deliver an outstanding client experience.
The Client…
Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.
Equine Gastric Ulceration…
Zoetis unveiled the Centre for Digital Innovation (CDI), it's new centre for creating digital products that enable data-driven decision-making to enhance precision farming and improve animal wellbeing for livestock and pets, at the House of Lords last week…
Zoetis Business Consulting has announced the launch of Profitsolver, a software tool designed to boost practice profits.
The software has already been rolled out in the US, where Zoetis says that it has delivered an average of £103,000 extra profit to…
Zoetis has announced the launch of Versican Plus, a vaccine range for dogs in the UK and throughout Europe.
Versican Plus is the only vaccine to combine DHPPi + L4 in a single injection1, something which Zoetis says is the fruit of several years research…
Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.
The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices…
Zoetis has announced that PropoFlo Plus is now back in stock following a huge surge in demand caused by supply issues with a competitor propofol.
Licensed for use in dogs and cats, PropoFlo Plus is an anaesthetic injection for the induction and maintenance…
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age…
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for…
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear…
Zoetis has announced the launch of Simparica, a once-monthly oral medication for the treatment of flea, tick and mite infestations in dogs beginning at eight weeks of age.
The company says the new product, which comes in the form of a tasty chewable…
Zoetis has announced a spring offer on Apoquel, its anti-pruritic for dogs.
The offer is timed to coincide with the expected increase in canine pruritis as the warmer weather leads to increased levels of common allergens such as pollen, dust mites…
Drawing attention to the symptoms of allergic skin disease that owners should…
Sileo provides a micro-dose of dexmedetomidine hydrochloride, a selective alpha-2 adrenoceptor agonist…
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used…
The company says it has been working hard to ensure improved supply on a number of brands including Apoquel, Palladia…